Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4851
Peoples Bancorp
PEBO
$1.48B
| $282K | ﹤0.01% |
10,417
-10,016
| -49% | -$245K |
|
4852
Mammoth Energy Services
TUSK
$142M
| $280K | ﹤0.01% |
62,893
-39,953
| -39% | -$97.2K |
|
|
ATTO
4853
DELISTED
Atento S.A.
ATTO
| $280K | ﹤0.01% |
20,599
| – | – |
|
|
WPG
4854
DELISTED
Washington Prime Group Inc.
WPG
| $280K | ﹤0.01% |
42,956
-26,129
| -38% | -$184K |
|
4855
Donegal Group Class A
DGICA
$725M
| $279K | ﹤0.01% |
19,799
+1,623
| +9% | +$23.3K |
|
4856
Marcus Corp
MCS
$944M
| $279K | ﹤0.01% |
20,702
-162,219
| -89% | -$1.64M |
|
4857
NI Holdings
NODK
$318M
| $278K | ﹤0.01% |
16,918
-1,323
| -7% | -$22.5K |
|
4858
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.6B
| $278K | ﹤0.01% |
6,600
| – | – |
|
|
YARW
4859
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
| $278K | ﹤0.01% |
49
+24
| +96% | +$151K |
|
4860
Microvision
MVIS
$76.1M
| $277K | ﹤0.01% |
+3,427
| New | +$151K |
|
4861
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.31B
| $276K | ﹤0.01% |
4,472
-16,504
| -79% | -$897K |
|
|
ADAP
4862
DELISTED
Adaptimmune Therapeutics
ADAP
| $275K | ﹤0.01% |
51,048
-535,395
| -91% | -$2.91M |
|
4863
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.83B
| $275K | ﹤0.01% |
9,942
-35,964
| -78% | -$932K |
|
|
MAXN
4864
DELISTED
Maxeon Solar Technologies
MAXN
| $275K | ﹤0.01% |
+97
| New | +$214K |
|
4865
Aquestive Therapeutics
AQST
$492M
| $274K | ﹤0.01% |
51,167
-29,160
| -36% | -$175K |
|
|
VNTR
4866
DELISTED
Venator Materials PLC
VNTR
| $273K | ﹤0.01% |
82,359
-1,880,492
| -96% | -$4.49M |
|
4867
OptimizeRx
OPRX
$126M
| $272K | ﹤0.01% |
8,743
-48,608
| -85% | -$1.19M |
|
4868
Sasol
SSL
$7.24B
| $272K | ﹤0.01% |
30,683
-70,269
| -70% | -$527K |
|
4869
iShares MSCI Netherlands ETF
EWN
$630M
| $270K | ﹤0.01% |
6,532
+100
| +2% | +$3.81K |
|
4870
Hurco Companies Inc
HURC
$142M
| $270K | ﹤0.01% |
+9,002
| New | +$274K |
|
4871
Genco Shipping & Trading
GNK
$1.1B
| $269K | ﹤0.01% |
36,525
-42,603
| -54% | -$310K |
|
4872
AC Immune
ACIU
$236M
| $267K | ﹤0.01% |
51,589
+12,268
| +31% | +$62.6K |
|
4873
Goldman Sachs ActiveBeta Japan Equity ETF
GSJY
$86.4M
| $267K | ﹤0.01% |
+7,190
| New | +$251K |
|
|
FIRY
4874
Firy Inc
FIRY
$156M
| $267K | ﹤0.01% |
+668
| New | +$199K |
|
4875
iShares MSCI Denmark ETF
EDEN
$202M
| $266K | ﹤0.01% |
+2,725
| New | +$246K |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.